Loading insider details...
Beta
Latest Form 4 (Jul 29, 2026): Purchase of 15,620 MPLT shares, $148.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | MapLight Therapeutics, Inc. (MPLT) | Purchase | 15,620 | $148.7K |
| Jun 25, 2026 | MapLight Therapeutics, Inc. (MPLT) | Grant/Award | 7,864 | n/a |
| Jun 23, 2026 | STANDARD BIOTOOLS INC. (LAB) | Grant/Award | 99,116 | n/a |
| Jun 22, 2026 | SOPHiA GENETICS SA (SOPH) | Grant/Award | 19,724 | $107.7K |
| Mar 3, 2026 | STANDARD BIOTOOLS INC. (LAB) | Grant/Award | 57,264 | $67.0K |
| Jun 24, 2025 | STANDARD BIOTOOLS INC. (LAB) | Grant/Award | 94,592 | n/a |
| Mar 4, 2025 | STANDARD BIOTOOLS INC. (LAB) | Grant/Award | 62,910 | $67.0K |
| Dec 12, 2024 | Zymeworks Inc. (ZYME) | Grant/Award | 31,000 | n/a |
| Jul 2, 2024 | STANDARD BIOTOOLS INC. (LAB) | Grant/Award | 43,128 | n/a |
| Jan 9, 2024 | STANDARD BIOTOOLS INC. (LAB) | Grant/Award | 87,057 | n/a |